HIV-infected persons treated with highly energetic antiretroviral therapy (HAART) continue to have elevated risk for non-Hodgkin lymphoma (NHL). of 3.4, 2.6, and 6.8, respectively, for 0.1-0.4, 0.5-1.4, and 1.5+ years vs. 0 years; p-trend=0.004). Although serum globulin levels were elevated…